ARS Pharmaceuticals, Inc. - ROE

The ROE as of June 2026 (TTM) for ARS Pharmaceuticals, Inc. (SPRY) is -153.61%

According to ARS Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -153.61%. This represents a change of 218.32% compared to the average of -48.26% of the last 4 quarters.

ARS Pharmaceuticals, Inc. (SPRY) Historical ROE (quarterly & annually)

How has SPRY ROE performed in the past?

The mean historical ROE of ARS Pharmaceuticals, Inc. over the last ten years is 27.55%. The current -153.61% ROE has changed -657.58% with respect to the historical average. Over the past ten years (40 quarters), SPRY's ROE was at its highest in in the December 2019 quarter at 124.40%. The ROE was at its lowest in in the March 2026 quarter at -98.87%.

ARS Pharmaceuticals, Inc. (SPRY) ROE by Quarter and Year

Discovering the peaks and valleys of ARS Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ARS Pharmaceuticals, Inc. (SPRY) Average ROE

How has SPRY ROE performed in the past?

The current ROE of ARS Pharmaceuticals, Inc. (SPRY) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

ARS Pharmaceuticals, Inc. (SPRY) ROE vs. Peers

How is SPRY’s ROE compared to its peers?

ARS Pharmaceuticals, Inc.’s ROE is greater than GH Research PLC (-19.83%), less than Nanobiotix S.A. (31.23%), less than Arbutus Biopharma Corporation (129.32%), greater than LENZ Therapeutics, Inc. (-46.82%), greater than Savara Inc. (-87.19%), greater than Rezolute, Inc. (-58.82%), greater than Kura Oncology, Inc. (-141.95%), less than ProKidney Corp. (7.40%), greater than Palvella Therapeutics, Inc. (-56.87%), greater than Tyra Biosciences, Inc. (-42.66%),

Build a custom stock screener for ARS Pharmaceuticals, Inc. (SPRY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARS Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ARS Pharmaceuticals, Inc. (SPRY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ARS Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.